Medpace Holdings (MEDP) Net Income towards Common Stockholders Growth (1y) (2016 - 2026)
Medpace Holdings (MEDP) Net Income towards Common Stockholders Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -159.32% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 9.95% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 7.86% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 14.74% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -27.15% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 57.67% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -44.49% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 2.29% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 3.59% |
| 10 | Medpace Holdings | 15.46 Bn | 14.81 Bn | 196.33 Mn | 8.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.09% |
| Dec 31, 2025 | 15.48% |
| Sep 30, 2025 | 15.25% |
| Jun 30, 2025 | 2.16% |
| Mar 31, 2025 | 11.70% |
| Dec 31, 2024 | 49.45% |
| Sep 30, 2024 | 36.68% |
| Jun 30, 2024 | 44.68% |
| Mar 31, 2024 | 40.74% |
| Dec 31, 2023 | 14.02% |
| Sep 30, 2023 | 6.85% |
| Jun 30, 2023 | 23.72% |
| Mar 31, 2023 | 18.89% |
| Dec 31, 2022 | 37.25% |
| Sep 30, 2022 | 35.93% |
| Jun 30, 2022 | 23.60% |
| Mar 31, 2022 | 41.58% |
| Dec 31, 2021 | -1.64% |
| Sep 30, 2021 | 17.16% |
| Jun 30, 2021 | 65.67% |